.png)
OPIS is a Global Full-Service clinical CRO providing premium clinical trial management for multi-country trials. In addition to phase I-IV drug-related trials, OPIS also manages pre-and post-marketing clinical investigations for medical/diagnostic devices and nutraceutical/food supplement studies. Founded in 1998, the company counts more than 15 offices around the world (Italy, Spain, France, Germany, UK, Belgium, Sweden, Poland, Serbia, Switzerland, Netherlands, Taiwan, Australia, Korea Japan and the US).
As data-driven and quality-focused clinical CRO, OPIS collaborates with numerous international Sponsors on multi-country interventional as well as non-interventional trials. OPIS teams have sound experience in a wide range of therapeutic areas, new-generation drugs, advanced therapeutic procedures and biological treatment options.
Medical and scientific expertise in combination with technological and operational know-how have earned OPIS established partnerships with numerous pharma and biotechnology and medical device clients.